CMRAX
Price
$10.08
Change
-$0.05 (-0.49%)
Updated
Jun 13 closing price
Net Assets
2.08M
HMEAX
Price
$19.56
Change
-$0.02 (-0.10%)
Updated
Jun 13 closing price
Net Assets
1.09B
Interact to see
Advertisement

CMRAX vs HMEAX

Header iconCMRAX vs HMEAX Comparison
Open Charts CMRAX vs HMEAXBanner chart's image
Calamos Merger Arbitrage A
Price$10.08
Change-$0.05 (-0.49%)
VolumeN/A
Net Assets2.08M
NexPoint Merger Arbitrage A
Price$19.56
Change-$0.02 (-0.10%)
VolumeN/A
Net Assets1.09B
CMRAX vs HMEAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMRAX vs. HMEAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMRAX is a StrongBuy and HMEAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HMEAX has more cash in the bank: 1.09B vs. CMRAX (2.08M). HMEAX pays higher dividends than CMRAX: HMEAX (4.79) vs CMRAX (1.13). CMRAX was incepted earlier than HMEAX: CMRAX (2 years) vs HMEAX (9 years). CMRAX (12.56) is less costly to investors than HMEAX (2.74). HMEAX is a more actively managed with annual turnover of: 556.00 vs. CMRAX (136.00). HMEAX initial investment is less costly to investors than CMRAX (3%) vs CMRAX (3%). CMRAX (2500) and HMEAX (2500) have matching initial minimum investment requirements. HMEAX (5.81) and CMRAX (5.56) have marching annual gain over last year.
CMRAXHMEAXCMRAX / HMEAX
Total Expense Ratio2.162.4987%
Annual Report Gross Expense Ratio12.562.74458%
Fund Existence2 years9 years-
Gain YTD2.2312.47090%
Front Load3%6%50%
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.08M1.09B0%
Annual Yield % from dividends1.134.7924%
Returns for 1 year5.565.8196%
Returns for 3 yearsN/A15.32-
Returns for 5 yearsN/A18.20-
Returns for 10 years-61.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX38.63N/A
N/A
Patient Opportunity A
VASVX27.49N/A
N/A
Vanguard Selected Value Inv
SESGX23.52N/A
N/A
Sit ESG Growth S
SJCIX30.79N/A
N/A
Steward Large Cap Core I
ARAQX10.62N/A
N/A
Aristotle Value Eq A